APPLICATION
ANDA216228
TYPE
ANDA
ROUTE
INJECTABLE
DOSAGE FORM
SUSPENSION, EXTENDED RELEASE
MARKETING STATUS
None (Tentative Approval)
Products
PALIPERIDONE PALMITATENone (Tentative Approval)
PALIPERIDONE PALMITATE 273MG/0.88ML · SUSPENSION, EXTENDED RELEASE · INJECTABLE
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.